Eton Pharmaceuticals

Home
United States
Deer Park, IL
Eton Pharmaceuticals

Eton Pharmaceuticals is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases.

06/19/2026

What a great few days at !

One of the things we enjoy most about this Endocrine Society meeting is spending time with the Endocrinology community that cares for patients with rare endocrine disorders. From pediatric specialists helping children receive the right diagnosis early to adult endocrinologists managing patients throughout their lives, the commitment to these patients inspires us at Eton Pharmaceuticals.

We had many conversations about patient identification, access to therapy, and the challenges patients, families, and care teams navigate every day. We also loved meeting so many fellows and trainees; the future of endocrinology is bright!

Thank you to everyone who stopped by to share ideas, experiences, and perspectives. We left with new insights, new relationships, and even more excitement for the work ahead at Eton!

05/25/2026

Memorial Day is one of the few days on the calendar centered not on celebration, but remembrance.

Today, we’re thinking about the servicemen and women whose lives were given in service to others, and the families who continue carrying that loss every single day.

At Eton, we spend a lot of time talking about care, commitment, and showing up for people during difficult moments. Memorial Day is a reminder that those values exist because of sacrifices much greater than ourselves.

It’s a time to pause, reflect, and remember those who gave everything for this country.

05/20/2026

Eton Pharmaceuticals announced the acquisition of U.S. Commercialization Rights to Impavido® (miltefosine) capsules.

“We are excited to add yet another 2026 product launch to our portfolio and look forward to partnering with Knight Therapeutics to ensure reliable, high-touch access to the medication for patients across the United States and serving this important community,” said Sean Brynjelsen, CEO of Eton.

Read the here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-expands-rare-disease-portfolio-through-0

We look forward to helping ensure patients receive timely access and dedicated support, where it can make a meaningful difference for this rare condition.

05/10/2026

This Mother’s Day, we’re thinking about the rare disease moms who live in two worlds at once.

The world of everyday life, filled with school pickups, birthday parties, homework, sports, and dinner tables.

And the world of medications, symptoms, insurance calls, specialist visits, emergency plans, and the constant mental checklist that never fully shuts off.

The moms who look completely like any of us on the outside while carrying an amount of stress and responsibility most people will never fully see.

We’ve had the privilege of meeting many of these mothers through the rare disease community, and their strength leaves a true impact on us every time.

To our , thank you for everything you carry, and everything you do.

05/07/2026

In celebration of National Nurses Week, we proudly recognize the compassion, dedication, and expertise that nurses bring to patients and families every day.

We recently had the opportunity to attend the Pediatric Endocrinology Nursing Society National Conference and connect with an incredible community of pediatric endocrine nurses.

We’re especially proud to recognize our own Catherine Gorman Moore, RN, who represented Eton at the meeting and led a product theater presentation. Her passion for supporting healthcare professionals and patients alike reflects the meaningful impact nurses make across every part of healthcare.

Thank you to all nurses for the care, commitment, and support you provide every single day.

Happy Nurses Week! 💙

05/05/2026

The Eton Pediatric Endocrinology team had a great time at meeting this weekend.

It was a pleasure connecting with the clinicians and trainees who are shaping the future of pediatric endocrinology. These conversations continue to reinforce the importance of collaboration, education, and long-term commitment to patient care.

We’re grateful for the opportunity to be part of this community.

05/01/2026

We’re excited to relaunch HEMANGEOL® (propranolol hydrochloride) oral solution.

With the move to Anovo Specialty Pharmacy and full integration of Eton Cares®, our mission is to make it easier for patients to start treatment and for families to get the support they need, from day one.

Grateful to be part of this special community and to support our providers, patients, and their loved ones along the way.

🔗 Read the full press release here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-relaunches-hemangeolr-propranolol-oral.

04/29/2026

We’re looking forward to being on the ground at three upcoming meetings and connecting with the clinicians and partners who care for patients living with rare diseases.

Please visit us at:
📍Pediatric Endocrine Society (PES) | April 30-May 2 | San Francisco, CA | Booth # 113
📍 Pediatric Endocrine Nursing Society (PENS) | April 29-May 1 | Columbus, OH | Booth # 110
📍 Digestive Disease Week (DDW) | May 2-5 | Chicago, IL | Booth # 2126

Each of these meetings brings together experts across specialties who play a critical role in diagnosis, treatment, and long-term care.

If you’re attending, we’d welcome the opportunity to connect.

04/27/2026

We’re pleased to share that Eton Pharmaceuticals has initiated a clinical study evaluating ET-700, an investigational extended-release formulation of zinc acetate.

🔗 Read the PR here: https://ir.etonpharma.com/news-releases/news-release-details/eton-pharmaceuticals-announces-initiation-clinical-study-product.

The study is designed as a randomized, double-blind, placebo-controlled trial and will use advanced imaging to better understand copper absorption in individuals living with Wilson disease.

This marks another meaningful step as we continue building our pipeline and our work in rare diseases that require lifelong care.

We’re grateful to the investigators, study participants, and broader community who make this work possible.

04/22/2026

We were thrilled to attend the CARES Foundation's 18th Annual Everyone CARES Gala at Sony Pictures Studios in Culver City, CA this past weekend.

The stories shared by parents, patients, and healthcare providers deeply involved in the care of those living with Congenital Adrenal Hyperplasia (CAH) were incredibly moving. There was a strong sense of gratitude, joy, and connection throughout the evening that stayed with us well beyond the event.

We thank the CARES Foundation for their incredible efforts to improve the lives of patients with CAH and for the support they have given to families, practitioners, and all those involved in the treatment of this disease.

Address

21925 W Field Pkwy #235
Deer Park, IL
60010

Website

https://www.etonpharma.com/

Alerts

Be the first to know and let us send you an email when Eton Pharmaceuticals posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Eton Pharmaceuticals:

Want your practice to be the top-listed Clinic in Deer Park?